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COMMENT
Sunglasses to hide behind may also prevent melanoma
of the eyes
Nathalie Dhomen1, Piyushkumar A. Mundra1 and Richard Marais 1
In 1967, Sandy Posey pronounced that sunglasses are essential beachwear (https://www.youtube.com/watch?v=4HVBEb-GA1Y).
Now, whole-genome sequencing reveals that ultraviolet radiation (UVR) can contribute to melanomas in the iris and conjunctiva,
data that provide a molecular explanation for why it is important to protect our eyes from exposure to UVR.
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The American Joint Committee on Cancer (AJCC) staging system
emphasises body site as important for melanoma diagnosis,1
because site predicts broad clinical characteristics and therefrom
therapeutic options. Common cutaneous melanomas (~90% of
cases) arise in the skin. More rarely, melanomas arise in the
mucosa (~1–2% of cases) of, for example, the gastrointestinal and
genitourinary tracts, and in the eyes (~5% of cases), either within
the uveal tract (choroid, iris and ciliary body) or in the conjunctiva
(the mucosa covering the sclera and lining the insides of the
eyelids) (see Fig. 1). Of particular concern, these rare melanoma
subtypes have limited treatment options.
Many epidemiological and experimental studies link common
cutaneous melanoma of non-glabrous skin to exposure to ultraviolet
radiation (UVR) and their genomes consequently show evidence of
direct UVR-induced DNA damage, presenting with high tumour
mutation burdens (TMBs), large numbers of C>T transitions and
predominance of a mutational process known as single base
substitution signature 7 (SBS7).2 Rare melanomas by contrast
generally have low TMB and low proportions of C>T transitions
and SBS7, but instead have large numbers of genome structural
variations (SVs) with characteristic chromosomal gains and losses.
The different melanoma subtypes are also driven by distinct
oncogenes. Cutaneous melanomas are typically driven by BRAF,
NRAS and NF1, with secondary mutations in hTERT and TP53. Mucosal
melanomas are driven by BRAF and NRAS but at a lower frequency
than cutaneous melanoma, and KIT is also a frequent driver in this
disease. Lastly, uveal melanomas are driven by GNAQ, GNA11 and
CYSLTR2, with secondary mutations in BAP1, SF3B1 and EIF1AX.3–6
Thus, different melanoma subtypes have distinct aetiologies,
but recent genomic evidence suggests that these distinctions are
not so clear-cut. In 2018, we reported that ~15% of common
cutaneous melanomas do not appear to be UVR-driven,2 causing
us to question by analogy if UVR is involved in some rare
melanomas. In this context, the eye is particularly intriguing,
because although the uveal tract is largely sun-protected, the iris
is sun-exposed, and the conjunctiva is unusual because it is a
partially sun-exposed mucosal membrane (Fig. 1). Sun exposure
causes conditions such as photokeratitis, pinguecula, pterygium,
cataracts and macular degeneration, and three recent papers now
establish that it also contributes to melanoma of the eye.
The first paper, from Nicholas Hayward and colleagues7
reported whole-genome sequencing (WGS) of 103 uveal melano-
mas. As expected, these melanomas generally presented low
TMBs, but eight were from the iris and they all presented high
TMB and SBS7 predominance. Intriguingly, despite this clear
evidence of UVR-induced DNA damage, the iris melanomas were
still driven by mutant GNAQ, GNA11 or CYSLTR2, and six samples
also had mutations in BAP1, EIF1AX or SF3B1.
The other two papers reported the genomic landscapes of
conjunctival melanomas. Following a brief earlier report,8 Carlo
Rivolta and colleagues9 have now analysed WGS on two
conjunctival melanomas and whole-exome sequencing on a
further 12. They reported high proportions of copy number
variants, but also high TMBs and high proportions of C>T
transitions. BRAF, NRAS, HRAS or NF1 were mutated in 12 lesions,
hTERT was mutated in nine, and TP53 was also mutated in nine.
Notably, SBS7 was predominant, but the association between
SBS7 and presumed sun exposure was weak.
In the third paper, we reported WGS of ten conjunctival
melanomas compared with eight other mucosal melanomas and
54 cutaneous melanomas.10 The conjunctival melanomas had
genome SVs that were similar to the other mucosal melanomas,
but nine also had high TMBs, high proportions of C>T transitions
and SBS7 predominance. Six of the nine had BRAF, NRAS and NF1
mutations, four had hTERT mutations, two had TP53 mutation, and
eight had mutations in 1 to 11 genes recurrently mutated in
common cutaneous melanoma. Notably, five of the SBS7-
dominant lesions were from the sun-exposed bulbar conjunctiva
and the non-SBS7 lesion was from the largely sun-protected
fornix, but one SBS7-dominant lesion spanned sun-exposed and
sun-protected sites and three were from the largely sun-protected
tarsal conjunctiva (Fig. 1). In our validation cohort, UVR involve-
ment was evident in some lip and gingiva mucosal melanomas,
which can be sun-exposed, but also in the nasal cavity and
oropharynx mucosal melanomas, which are sun-protected. Thus,
our data also showed a weak association between UVR signatures
and presumed sun exposure sites.
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There is interesting biology to explore, but these data show that
UVR plays a role in uveal melanomas in the iris, most conjunctival
melanomas and some mucosal melanomas at other sun-exposed
sites. Curiously, despite clear UVR signatures, the iris melanomas
were still driven by uveal melanoma oncogenes and the
conjunctival melanomas still had the genomic SVs characteristic
of mucosal melanoma. It is unclear what drives mutagenesis in
uveal and mucosal melanomas, but the persistence of baseline
genomic features in the UVR-driven lesions suggests that they are
peculiar to the different microenvironments in which melanocytes
reside, and we posit that UVR accelerates melanomagenesis at
various sites by imposing additional events over the existing site-
specific processes. That 15% of skin melanomas do not appear to
be UVR-driven2 suggests that the skin microenvironment also has
an underlying process that can be accelerated by UVR.
These new findings have two important implications. First, they
show that UVR can damage melanocytes in the eye to drive
melanomagenesis, emphasising the importance of public health
campaigns advocating sunglasses to protect the eyes from UVR.
This is especially important in strong sunlight, such as on the
beach or during activities including driving, boating and skiing.
Second, the genomes of UVR-driven rare melanomas are
remarkably similar to those of UVR-driven cutaneous melanomas
for which targeted therapies and immunotherapies are approved,
and we advocate therefore that UVR-driven rare melanomas
should be considered for these therapies. Accepting the eye as an
immune-privileged site, we nevertheless advocate immunothera-
pies for UVR-driven iris melanoma, particularly in the metastatic
setting. For UVR-driven conjunctival and other mucosal melano-
mas, we again advocate immunotherapies, or if tractable BRAF
mutations are present, BRAF/MEK inhibitors. As described above,
the site of a melanoma does not immediately implicate UVR.
Therefore, to facilitate administration of these drugs, we propose a
simple assay based on targeted sequencing of only ten genes
(LRP1B, GPR98, XIRP2, PKHD1L1, USH2A, DNAH9, PCDH15, DNAH10,
TP53 and PCDHAC1) that can reveal UVR involvement with
reasonable certainty, and which is more convenient and cost-
effective than WGS.2,10
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Fig. 1 Areas of the eye in which melanoma arises. Sagittal cross-section and frontal view of the eye indicating the location of the
components of the uveal tract (choroid, ciliary body and iris; red) and the conjunctiva (tarsal conjunctiva, fornix and bulbar conjunctiva; blue).
The iris and bulbar conjunctiva are the sun-exposed areas of the uveal tract and conjunctiva respectively. Created with BioRender.com.
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